Protagonist Therapeutics, Inc. (PTGX) is a clinical-stage biopharmaceutical company focused on developing innovative peptide-based therapies aimed at addressing significant unmet medical needs, particularly in gastrointestinal disorders and hematological diseases. Leveraging its proprietary peptide technology platform, Protagonist is advancing a robust pipeline of therapeutic candidates designed to enhance patient outcomes. Based in Newark, California, the company is strategically positioned to drive scientific innovation and tackle critical healthcare challenges through a strong commitment to research and development.
Click "Analyze" to generate stock analysis
PTGX Price Trend and Signals
PTGX Option Volumes & Open Interests (aggregated)
PTGX Put Call Ratios and IV (aggregated)
PTGX Financials
2025-10-22Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-13Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-13Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-13Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-13Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.
2025-10-10Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-10Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-10Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-10Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-10Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.